Cel-Sci Total Assets 2006-2021 | CVM

Cel-Sci total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Cel-Sci Annual Total Assets
(Millions of US $)
2020 $41
2019 $28
2018 $30
2017 $23
2016 $25
2015 $29
2014 $19
2013 $11
2012 $16
2011 $19
2010 $38
2009 $46
2008 $15
2007 $21
2006 $10
2005 $3
Cel-Sci Quarterly Total Assets
(Millions of US $)
2021-03-31 $48
2020-12-31 $50
2020-09-30 $41
2020-06-30 $44
2020-03-31 $37
2019-12-31 $31
2019-09-30 $28
2019-06-30 $28
2019-03-31 $25
2018-12-31 $26
2018-09-30 $30
2018-06-30 $22
2018-03-31 $23
2017-12-31 $22
2017-09-30 $23
2017-06-30 $22
2017-03-31 $22
2016-12-31 $23
2016-09-30 $25
2016-06-30 $14
2016-03-31 $16
2015-12-31 $20
2015-09-30 $29
2015-06-30 $21
2015-03-31 $13
2014-12-31 $20
2014-09-30 $19
2014-06-30 $25
2014-03-31 $22
2013-12-31 $25
2013-09-30 $11
2013-06-30 $15
2013-03-31 $18
2012-12-31 $22
2012-09-30 $16
2012-06-30 $20
2012-03-31 $18
2011-12-31 $17
2011-09-30 $19
2011-06-30 $24
2011-03-31 $31
2010-12-31 $34
2010-09-30 $38
2010-06-30 $42
2010-03-31 $45
2009-12-31 $49
2009-09-30 $46
2009-06-30 $19
2009-03-31 $14
2008-12-31 $14
2008-09-30 $15
2008-06-30 $15
2008-03-31 $18
2007-12-31 $19
2007-09-30 $21
2007-06-30 $21
2007-03-31 $7
2006-12-31 $8
2006-09-30 $10
2006-06-30 $3
2006-03-31 $3
2005-12-31 $3
2005-09-30 $3
2005-06-30 $3
2005-03-31 $3
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.912B $0.001B
CEL-SCI CORP. was formed to acquire and finance research and development of natural human interleukin-2 (``IL-2``) and lymphokine-related products and processes using the Co.'s proprietary cell culture technologies. The Co.'s proprietary product is sometimes referred to as MULTIKINEn, or buffy-coat interleukins, which is a combination, or ``cocktail`` of IL-2 and certain lymphokines and cytokines. MULTIKINE is a trade name of Co. Since its inception the focus of the Co.'s product development efforts has been on conducting clinical trials to test its proprietary technologies.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $148.417B 10.29
Amgen (AMGN) United States $137.135B 14.80
CSL (CSLLY) Australia $103.877B 0.00
Gilead Sciences (GILD) United States $83.541B 8.89
Moderna (MRNA) United States $79.980B 159.35
Illumina (ILMN) United States $66.599B 96.03
Biogen (BIIB) United States $58.481B 13.39
Regeneron Pharmaceuticals (REGN) United States $57.312B 16.41
BioNTech SE (BNTX) Germany $51.304B 37.20
Vertex Pharmaceuticals (VRTX) United States $48.628B 20.03
Alexion Pharmaceuticals (ALXN) United States $39.936B 15.17
BeiGene (BGNE) Cayman Islands $29.612B 0.00
Seagen (SGEN) United States $28.367B 49.00
Genmab (GMAB) Denmark $28.164B 33.01
Genmab (GNMSF) Denmark $26.248B 6.04
Exact Sciences (EXAS) United States $21.705B 0.00
Horizon Therapeutics Public (HZNP) Ireland $21.265B 27.19
Alnylam Pharmaceuticals (ALNY) United States $20.793B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Incyte (INCY) United States $18.465B 36.50
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $16.797B 88.32
ARGENX SE-ADR (ARGX) Netherlands $16.323B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.967B 136.50
Zai Lab (ZLAB) China $14.929B 0.00
Novavax (NVAX) United States $12.923B 0.00
Guardant Health (GH) United States $12.155B 0.00
CureVac (CVAC) Germany $11.577B 0.00
Repligen (RGEN) United States $10.835B 97.69
QIAGEN (QGEN) Netherlands $10.743B 19.08
CRISPR Therapeutics AG (CRSP) Switzerland $9.686B 0.00
Denali Therapeutics (DNLI) United States $8.936B 320.57
Mirati Therapeutics (MRTX) United States $8.568B 0.00
Acceleron Pharma (XLRN) United States $7.784B 0.00
Ascendis Pharma (ASND) Denmark $7.587B 0.00
Fate Therapeutics (FATE) United States $7.544B 0.00
Exelixis (EXEL) United States $7.023B 112.05
Ultragenyx Pharmaceutical (RARE) United States $6.405B 0.00
Sarepta Therapeutics (SRPT) United States $6.330B 0.00
AbCellera Biologics (ABCL) $6.283B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.181B 0.00
Vir Biotechnology (VIR) United States $6.001B 0.00
Halozyme Therapeutics (HALO) United States $5.896B 32.35
SWEDISH ORP BIO (BIOVF) Sweden $5.628B 20.39
Adaptive Biotechnologies (ADPT) United States $5.535B 0.00
Twist Bioscience (TWST) United States $5.439B 0.00
Beam Therapeutics (BEAM) United States $5.319B 0.00
I-Mab (IMAB) China $5.315B 0.00
Intellia Therapeutics (NTLA) United States $5.174B 0.00
NeoGenomics (NEO) United States $5.085B 862.40
Legend Biotech (LEGN) United States $5.053B 0.00
Reata Pharmaceuticals (RETA) United States $5.006B 0.00
Apellis Pharmaceuticals (APLS) United States $4.839B 0.00
Galapagos (GLPG) Belgium $4.834B 0.00
Blueprint Medicines (BPMC) United States $4.830B 14.70
Certara (CERT) United States $4.224B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.169B 0.00
Arena Pharmaceuticals (ARNA) United States $4.069B 0.00
SpringWorks Therapeutics (SWTX) United States $3.931B 0.00
Alkermes (ALKS) Ireland $3.918B 0.00
Arvinas (ARVN) United States $3.878B 0.00
Intra-Cellular Therapies (ITCI) United States $3.506B 0.00
Emergent Biosolutions (EBS) United States $3.245B 6.46
Berkeley Lights (BLI) United States $3.244B 0.00
Insmed (INSM) United States $3.012B 0.00
Vericel (VCEL) United States $2.844B 766.88
BAVARIAN NORDIC (BVNRY) Denmark $2.814B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.782B 0.00
Amicus Therapeutics (FOLD) United States $2.642B 0.00
MorphoSys AG (MOR) Germany $2.547B 0.00
Sorrento Therapeutics (SRNE) United States $2.472B 0.00
Editas Medicine (EDIT) United States $2.434B 0.00
Heska (HSKA) United States $2.407B 1049.36
ALX Oncology Holdings (ALXO) United States $2.385B 0.00
Morphic Holding (MORF) United States $2.328B 0.00
Instil Bio (TIL) United States $2.320B 0.00
Global Blood Therapeutics (GBT) United States $2.281B 0.00
Prothena (PRTA) Ireland $2.253B 0.00
Bluebird Bio (BLUE) United States $2.236B 0.00
Myriad Genetics (MYGN) United States $2.204B 0.00
Revance Therapeutics (RVNC) United States $2.174B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.166B 0.00
Kymera Therapeutics (KYMR) United States $2.132B 0.00
Bionano Genomics (BNGO) United States $2.125B 0.00
Ligand Pharmaceuticals (LGND) United States $2.108B 35.27
Seer (SEER) $2.045B 0.00
Seres Therapeutics (MCRB) United States $2.001B 0.00
Amarin (AMRN) Ireland $1.958B 0.00
Atea Pharmaceuticals (AVIR) United States $1.935B 0.00
Myovant Sciences (MYOV) United Kingdom $1.926B 0.00
Genetron Holdings (GTH) China $1.873B 0.00
Protagonist Therapeutics (PTGX) United States $1.866B 0.00
Castle Biosciences (CSTL) United States $1.841B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.782B 0.00
Inovio Pharmaceuticals (INO) United States $1.778B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.767B 0.00
PHARMA MAR SA (PHMMF) Spain $1.697B 0.00
Alector (ALEC) United States $1.693B 0.00
Zymeworks (ZYME) Canada $1.674B 0.00
C4 Therapeutics (CCCC) United States $1.638B 0.00
Arcus Biosciences (RCUS) United States $1.637B 0.00
Sangamo Therapeutics (SGMO) United States $1.632B 0.00
REGENXBIO (RGNX) United States $1.604B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.602B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.578B 0.00
NGM Biopharmaceuticals (NGM) United States $1.569B 0.00
Cytokinetics (CYTK) United States $1.529B 0.00
UniQure (QURE) Netherlands $1.513B 0.00
PureTech Health (PRTC) United States $1.464B 0.00
Codexis (CDXS) United States $1.427B 0.00
Avid Bioservices (CDMO) United States $1.408B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.377B 0.00
MiMedx (MDXG) United States $1.369B 0.00
Zealand Pharma (ZEAL) Denmark $1.340B 0.00
BioAtla (BCAB) United States $1.331B 0.00
Precigen (PGEN) United States $1.311B 0.00
Ocugen (OCGN) United States $1.302B 0.00
Nurix Therapeutics (NRIX) United States $1.283B 0.00
Northwest Biotherapeutics (NWBO) United States $1.264B 0.00
Repare Therapeutics (RPTX) Canada $1.259B 0.00
Keros Therapeutics (KROS) United States $1.253B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.231B 0.00
Shattuck Labs (STTK) United States $1.229B 0.00
Agenus (AGEN) United States $1.170B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
Mesoblast (MESO) Australia $1.103B 0.00
Celldex Therapeutics (CLDX) United States $1.100B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.077B 0.00
Coherus BioSciences (CHRS) United States $1.072B 0.00
Scholar Rock Holding (SRRK) United States $1.067B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.065B 33.63
MannKind (MNKD) United States $1.061B 0.00
Pliant Therapeutics (PLRX) United States $1.038B 0.00
Dynavax Technologies (DVAX) United States $1.023B 0.00
Avidity Biosciences (RNA) United States $1.008B 0.00
Inhibrx (INBX) United States $1.005B 0.00
VBI Vaccines (VBIV) United States $0.996B 0.00
Prometheus Biosciences (RXDX) United States $0.992B 0.00
Travere Therapeutics (TVTX) United States $0.958B 0.00
Mersana Therapeutics (MRSN) United States $0.957B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.928B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.924B 0.00
Sutro Biopharma (STRO) United States $0.919B 0.00
G1 THERAPEUTICS (GTHX) United States $0.881B 0.00
Epizyme (EPZM) United States $0.876B 0.00
Nkarta (NKTX) United States $0.869B 0.00
RAPT THERAPTICS (RAPT) United States $0.865B 0.00
Merus (MRUS) Netherlands $0.838B 0.00
Verastem (VSTM) United States $0.820B 0.00
Affimed (AFMD) Germany $0.790B 0.00
SESEN BIO, INC (SESN) United States $0.754B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
IDEAYA Biosciences (IDYA) United States $0.747B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.739B 0.00
Pharming Group (PHAR) Netherlands $0.737B 0.00
Cara Therapeutics (CARA) United States $0.728B 63.26
Clene (CLNN) United States $0.708B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.692B 0.00
Curis (CRIS) United States $0.690B 0.00
Kadmon Holdings (KDMN) United States $0.686B 0.00
MeiraGTx Holdings (MGTX) United States $0.680B 0.00
Cellectis S.A (CLLS) France $0.675B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.670B 0.00
AnaptysBio (ANAB) United States $0.666B 0.00
DBV Technologies S.A (DBVT) France $0.666B 0.00
ALBIREO PHARMA (ALBO) United States $0.658B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.657B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Clovis Oncology (CLVS) United States $0.624B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.614B 0.00
ChromaDex (CDXC) United States $0.611B 0.00
Adagene (ADAG) China $0.609B 0.00
Precision BioSciences (DTIL) United States $0.605B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.599B 0.00
Geron (GERN) United States $0.583B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.578B 0.00
Bolt Biotherapeutics (BOLT) United States $0.577B 0.00
AC Immune SA (ACIU) Switzerland $0.576B 0.00
Anika Therapeutics (ANIK) United States $0.576B 0.00
Inventiva S.A (IVA) France $0.561B 0.00
Compugen (CGEN) Israel $0.535B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.534B 0.00
Selecta Biosciences (SELB) United States $0.532B 0.00
Codiak BioSciences (CDAK) United States $0.532B 0.00
Forte Biosciences (FBRX) United States $0.527B 0.00
Starpharma Holdings (SPHRY) Australia $0.512B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Gritstone Bio (GRTS) United States $0.485B 0.00
XBiotech (XBIT) United States $0.478B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.475B 0.00
CytomX Therapeutics (CTMX) United States $0.467B 0.00
BeyondSpring (BYSI) United States $0.457B 0.00
Athenex (ATNX) United States $0.440B 0.00
Oncobiologics (OTLK) United States $0.437B 0.00
Spero Therapeutics (SPRO) United States $0.435B 0.00
Neoleukin Therapeutics (NLTX) United States $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.422B 0.00
Kindred Biosciences (KIN) United States $0.416B 0.00
AquaBounty Technologies (AQB) United States $0.415B 0.00
ANI Pharmaceuticals (ANIP) United States $0.408B 11.25
Angion Biomedica (ANGN) United States $0.405B 0.00
Puma Biotechnology (PBYI) United States $0.399B 0.00
Cue Biopharma (CUE) United States $0.395B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.381B 0.00
Kala Pharmaceuticals (KALA) United States $0.379B 0.00
SQZ Biotechnologies (SQZ) United States $0.376B 0.00
WAVE Life Sciences (WVE) Singapore $0.361B 0.00
Opthea (OPT) Australia $0.361B 0.00
Adverum Biotechnologies (ADVM) United States $0.359B 0.00
BioDelivery Sciences (BDSI) United States $0.359B 14.56
Cogent Biosciences (COGT) United States $0.356B 0.00
Theratechnologies (THTX) Canada $0.351B 0.00
Cerecor (CERC) United States $0.350B 0.00
Athersys (ATHX) United States $0.349B 0.00
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.347B 0.00
UROGEN PHARMA (URGN) United States $0.344B 0.00
XOMA (XOMA) United States $0.343B 160.05
Frequency Therapeutics (FREQ) United States $0.341B 0.00
Fortress Biotech (FBIO) United States $0.341B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
Adicet Bio (ACET) United States $0.335B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.316B 0.00
Arbutus Biopharma (ABUS) United States $0.313B 0.00
Trevena (TRVN) United States $0.312B 0.00
Cardiff Oncology (CRDF) United States $0.300B 0.00
OVID THERAPEUTC (OVID) United States $0.296B 2.91
CorMedix Inc (CRMD) United States $0.293B 0.00
Kaleido Biosciences (KLDO) $0.286B 0.00
Innate Pharma S.A (IPHA) France $0.284B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Fulcrum Therapeutics (FULC) United States $0.281B 0.00
Clearside Biomedical (CLSD) United States $0.279B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.274B 0.00
Bellus Health (BLU) Canada $0.264B 0.00
INmune Bio (INMB) United States $0.261B 0.00
Kamada (KMDA) Israel $0.256B 17.39
Talis Biomedical (TLIS) United States $0.251B 0.00
HOOKIPA Pharma (HOOK) United States $0.246B 0.00
Chiasma (CHMA) United States $0.244B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.242B 0.00
Seelos Therapeutics (SEEL) United States $0.237B 0.00
Synlogic (SYBX) United States $0.225B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.223B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
NextCure (NXTC) United States $0.217B 0.00
TELA Bio (TELA) United States $0.217B 0.00
Checkpoint Therapeutics (CKPT) United States $0.212B 0.00
Aptinyx (APTX) United States $0.211B 0.00
VTv Therapeutics (VTVT) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.196B 0.00
Applied Genetic Technologies (AGTC) United States $0.190B 0.00
Biofrontera AG (BFRA) Germany $0.185B 0.00
OSMOTICA PHARM (OSMT) United States $0.181B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.180B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
X4 Pharmaceuticals (XFOR) United States $0.176B 0.00
Galena Biopharma (SLS) United States $0.172B 0.00
ObsEva SA (OBSV) Switzerland $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
PHASEBIO PHARMA (PHAS) United States $0.170B 0.00
Voyager Therapeutics (VYGR) United States $0.169B 4.36
Abeona Therapeutics (ABEO) United States $0.168B 0.00
Antibe Therapeutics (ATBPF) Canada $0.157B 0.00
Cyclerion Therapeutics (CYCN) United States $0.150B 0.00
DiaMedica Therapeutics (DMAC) United States $0.150B 0.00
Eton Pharmaceuticals (ETON) United States $0.147B 0.00
Exicure (XCUR) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.141B 41.57
Eyenovia (EYEN) United States $0.138B 0.00
Longeveron (LGVN) United States $0.137B 0.00
Catalyst Biosciences (CBIO) United States $0.136B 0.00
Liquidia Technologies (LQDA) United States $0.136B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.136B 0.00
Novogen (KZIA) Australia $0.134B 0.00
LogicBio Therapeutics (LOGC) United States $0.130B 0.00
Erytech Pharma SA (ERYP) France $0.130B 0.00
Liminal BioSciences (LMNL) Canada $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.127B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Yumanity Therapeutics (YMTX) United States $0.124B 0.00
Aptevo Therapeutics (APVO) United States $0.122B 0.00
Orgenesis (ORGS) United States $0.119B 0.00
Aytu BioPharma (AYTU) United States $0.119B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.118B 0.00
ABVC BioPharma (ABVC) United States $0.116B 0.00
Evofem Biosciences (EVFM) United States $0.113B 0.00
TRACON Pharmaceuticals (TCON) United States $0.113B 0.00
Beyond Air (XAIR) United States $0.112B 0.00
Vyant Bio (VYNT) United States $0.110B 0.00
Vascular Biogenics (VBLT) Israel $0.107B 0.00
AEterna Zentaris (AEZS) United States $0.107B 0.00
Celsion (CLSN) United States $0.107B 0.00
Entera Bio (ENTX) Israel $0.105B 0.00
Zosano Pharma (ZSAN) United States $0.105B 0.00
Leap Therapeutics (LPTX) United States $0.104B 0.00
ARAVIVE, INC (ARAV) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.098B 0.00
Evogene (EVGN) Israel $0.094B 0.00
Dyadic (DYAI) United States $0.092B 0.00
Lumos Pharma (LUMO) United States $0.090B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.089B 0.00
AIkido Pharma (AIKI) United States $0.087B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.085B 0.00
BioCardia (BCDA) United States $0.082B 0.00
Cleveland BioLabs (CBLI) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Celyad SA (CYAD) Belgium $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
ARIDIS PHARMACT (ARDS) United States $0.075B 0.00
Edesa Biotech (EDSA) Canada $0.074B 0.00
ATyr Pharma (LIFE) United States $0.072B 0.00
Advaxis (ADXS) United States $0.067B 0.00
Cyclo Therapeutics (CYTH) United States $0.067B 0.00
Viridian Therapeutics (VRDN) United States $0.066B 0.00
Alimera Sciences (ALIM) United States $0.066B 0.00
Genetic Technologies (GENE) Australia $0.063B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Pulmatrix (PULM) United States $0.058B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.058B 0.00
Windtree Therapeutics (WINT) United States $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.052B 0.00
Enveric Biosciences (ENVB) United States $0.046B 0.00
Soligenix (SNGX) United States $0.045B 0.00
Invo BioScience (INVO) United States $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 1.02
Happiness Biotech Group (HAPP) China $0.040B 0.00
Vallon Pharmaceuticals (VLON) United States $0.036B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
GeoVax Labs (GOVX) United States $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
ZIVO Bioscience (ZIVO) United States $0.023B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00